A collaboration between EARA member institutions in Germany, has created a new approach to fight blood cancer.
Using two mouse models, scientists at the Max Delbrück Center for Molecular Medicine (MDC) and Charité – Universitätsmedizin Berlin changed immune cells of the mice in the lab and then used these to target the cancer.
The findings, published in Nature Communications, show that this immunotherapy is safe and effective against the most common type of blood cancer in adults.
“We are already co-operating with two cancer specialists at Charité and are currently working with them to prepare a phase 1/2 clinical trial,” said Armin Rehm, Head of the Translational Tumorimmunology lab at MDC.